Loading company…
VIVEBiotech is a Spanish CDMO that develops and manufactures lentiviral vectors for gene therapies and vaccines.
Founded in 2015 and headquartered in Donostia, Spain, VIVEBiotech S.L. serves more than 40 biotech clients worldwide and produces lentiviral vectors in line with EMA and FDA requirements. Revenue comes from B2B contracts. The company reported revenue of EUR 15,535,675.80 and EBITDA of EUR 2,609,613.70 for 2023. In December 2024 it raised EUR 1.1 mn from the Center for Technological & Industrial Development, Easo Ventures and Inveready Asset Management to expand manufacturing in Spain.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in